The Harvard Drug Group LLC recalls Midodrine Hydrochloride Tablets
- Published
- 11 Mar 2026
- Units affected
- 8892 cartons
- Agency
- FDA
- Country
- United States
The hazard
Defective container; inadequately sealed blister packaging.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
- Brand / company
- The Harvard Drug Group LLC
- Codes / lots
- Lot # N02640, Exp Date: 08/2027
- Distribution
- Nationwide US.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 11 Mar 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.